Trials / Completed
CompletedNCT05076409
A Study in Healthy Men to Test How Fluconazole Influences the Amount of BI 425809 in the Blood
Effect of Fluconazole on the Pharmacokinetics of a Single Oral Dose of BI 425809 in Healthy Male Subjects (an Open-label, Two-period Fixed-sequence Design Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect of fluconazole, under steady state conditions on the pharmacokinetics of BI 425809 (Reference Treatment R: BI 425809 alone; Test Treatment T: BI 425809 given under steady state conditions of fluconazole).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 425809 | Period 1 and period 2 |
| DRUG | fluconazole | Period 2 |
Timeline
- Start date
- 2021-10-19
- Primary completion
- 2022-01-10
- Completion
- 2022-01-10
- First posted
- 2021-10-13
- Last updated
- 2024-09-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05076409. Inclusion in this directory is not an endorsement.